It’s been 55 days since I had surgery for breast cancer. I still haven’t received a single follow-up treatment — not radiation, not hormonal therapy, not even a doctor. Not for lack of trying. Not because I didn’t want care. But because the system failed me — repeatedly, predictably, and with complete indifference.

Let me be clear: I am a woman with health insurance. I pay nearly $11,000 a year in premiums. And I cannot get care.

A Diagnosis in a Desert of Doctors

In April, I underwent a lumpectomy after being diagnosed with invasive ductal carcinoma. It’s stage 1. Treatable. But timing is everything when you’re trying to prevent recurrence. Post-surgical treatment should start within weeks. Mine hasn’t.

Emory University, one of Atlanta’s largest providers, couldn’t offer me an appointment with a female breast oncologist for at least 6 weeks. The level of care at Emory was atrocious throughout the diagnosis process, and I’d already waited weeks just to get a diagnosis. I couldn’t wait longer.

Eventually, I found a facility almost 50 miles from home — City of Hope in Newnan, GA. It promised compassionate care, collaborative treatment planning, and an all-female treatment team. I trusted their pink ribbons and mission statements. What I got was chaos.

City of Broken Promises

Over the course of 60 days at City of Hope in Newnan, I tried to trust the process. I drove nearly 50 miles each way through Atlanta traffic for every appointment, believing that a facility dedicated to cancer care would have its act together. But every visit chipped away at my confidence.

I’d had concerns from the very moment I began interacting with my treatment team at City of Hope. The first thing the surgeon said to me after diagnosis was literally, “What kind of surgery do you want?” My diagnosis has come from a lab report and this was my first interaction with any doctor on the subject.

I got a feel for how over-capacity the hospital was at my post-surgical appointment with my medical oncologist, Dr. Sharm. That’s when I learned that two weeks post-surgery, they had never ordered the oncotype testing for the tumor that was removed during my surgery. According to Dr. Sharma, that test is critical — it determines whether chemotherapy is necessary — and takes 2–3 weeks to process. By failing to order it, they had guaranteed another delay.

Dr. Sharma also referenced hormone receptor results that contradicted the biopsy results I’d received earlier. She acknowledged that the numbers looked “off” and agreed it was highly likely they were incorrect. But when I them to rerun the test, she said she’d “let me know if she thought that was necessary.” The practice responded that it was ‘just a typo’ and they “hope that this helps answer some of your questions.” It didn’t. I insisted the test be redone. The new results were — again — different.

This wasn’t a simple lab typo. This was the foundation of my treatment plan being casually mishandled. I filed a formal complaint with the hospital and requested to be assigned a new female oncologist. Over the next 4 weeks, I called and emailed everyone I could at City of Hope. After a month of waiting — with no new oncologist, no plan, and no direct responses — I received a letter via FedEx saying they didn’t have another female oncologist available to treat me. Despite marketing themselves as a patient-centered cancer center, they couldn’t — or wouldn’t — deliver the basic standard of care.

Ghost Networks and Insurance Games

At this point, I had tried to get treatment from the two largest and highest-rated hospital systems in metro Atlanta — Emory and City of Hope. Both are in my Aetna network. Both advertise world-class cancer care. And both failed to provide me with access to a female oncologist in a timely or reliable way. Their names are on the list. Their services are not truly available. That’s what’s called a ghost network — a system that exists on paper, not in practice.

To seek treatment elsewhere, I needed Aetna to approve what’s called a network gap exception — an acknowledgment that no one in-network has the capacity to treat me, so they’ll allow out-of-area care at in-network rates. That’s where the Catch-22 began.

To even apply for a network gap exception, Aetna requires a pre-certification. And while they won’t say it outright, they make it nearly impossible for a patient to submit it themselves. Instead, I was repeatedly told that my doctor needed to initiate the request.

But here’s the problem: I don’t have a doctor who is willing to say, “We can’t treat her.” Why would they? That admission could jeopardize their reimbursement, reputation, or compliance obligations. It’s not in the hospital’s interest to acknowledge a capacity gap — even when it’s real and harmful. So the insurer wants a physician to say something no hospital is ever going to admit, and without that admission, I can’t get the approval I need.

I called Aetna’s pre-certification department multiple times. I spent over six hours on the phone trying to understand the process and explain the situation. I was told, again and again, “Have your doctor call.” When I tried to explain that I had no doctor willing to make that call, two separate Aetna representatives refused to take my application and refused to transfer me to a supervisor.

So I gathered everything myself — my diagnosis, provider details, relevant codes — and sent the application in writing by FedEx to Aetna’s pre-cert department. It was delivered on June 12. When I followed up on June 16, I was told there was no record of it.

Meanwhile, my scheduled appointment at Northwestern was canceled because I couldn’t guarantee coverage. Not because I didn’t try. But because I’m trapped in a system where the people with the power to approve my care won’t even accept the paperwork.

What’s the Cost of Delay?

We’re now approaching two months since I had surgery. And I still don’t even have a doctor to treat me.

In a typical cancer treatment plan, surgery is just the beginning. What comes next — chemotherapy, radiation, or hormonal therapies — is what kills the remaining cancer cells and reduces the risk of recurrence or spread. That next step should have started weeks ago. Every day that passes without treatment increases the chance that microscopic cancer cells — too small to detect now — will grow or spread to other parts of my body. If that happens, it may not be diagnosed for years. And when it is, it may no longer be treatable.

The system knows this. The science is clear. But the system also knows delay is profitable.

Aetna CVS Health, my insurer, has already announced it’s pulling out of the ACA healthcare exchange as of January 1, 2026. If they delay my care long enough, they may not have to pay at all. They keep collecting premiums while I go untreated. And if I die years from now because this cancer spread while I was waiting for care? Aetna won’t even exist in this market anymore. There will be no one to hold accountable. The incentives are aligned against me. Delay carries no risk for them. But it carries every risk for me.

And can you imagine what it’s like to wake up each morning knowing that your only goal for the day is to find someone — anyone — who will treat your cancer?

That’s where I am now. That’s the cost of delay.

Read more at https://cherylwilsongriffin.com/life-x-cheryl/